Pharmacotherapy and revascularization strategies of peripheral artery disease

Curr Probl Cardiol. 2024 Apr;49(4):102430. doi: 10.1016/j.cpcardiol.2024.102430. Epub 2024 Feb 1.

Abstract

The global epidemiological transition of atherosclerotic vascular diseases is witnessing a rapid redistribution of its burden, shifting from high-income to low- and middle-income countries. With a wide clinical spectrum, spanning from intermittent claudication to more complex critical limb threatening ischemia, nonhealing ulcers, gangrene as well as acute limb ischemia, peripheral artery disease is often faced with the challenges of under-diagnosis and under-treatment despite its high prevalence. The management of peripheral arterial disease in patients with multiple comorbidities presents a formidable challenge and remains a pressing global health concern. In this review, we aim to provide an in-depth overview of the pathophysiology of peripheral artery disease and explore evidence-based management strategies encompassing pharmacological, lifestyle, interventional, and surgical approaches. By addressing these challenges, the review contributes to a better understanding of the evolving landscape of peripheral artery disease, offering insights into effective and holistic management strategies.

Keywords: Pad; Peripheral artery disease; Revascularization.

Publication types

  • Review

MeSH terms

  • Atherosclerosis*
  • Comorbidity
  • Humans
  • Intermittent Claudication / therapy
  • Ischemia / diagnosis
  • Ischemia / therapy
  • Peripheral Arterial Disease* / therapy